Macrogenics (MGNX) Change in Account Payables (2012 - 2017)
Macrogenics (MGNX) posted quarterly Change in Account Payables of $197000.0 for Q2 2017, up 496.97% year-over-year from $33000.0 in Q2 2016, and up 108.86% quarter-over-quarter from -$2.2 million in Q1 2017.
Powered by 
Analysis
Macrogenics (MGNX) Change in Account Payables (2012 - 2017) Analysis & Trends
Macrogenics (MGNX) has reported Change in Account Payables for 6 consecutive years, with $197000.0 the latest figure, recorded in Q2 2017.
- In Q2 2017, Change in Account Payables rose 496.97% year-over-year to $197000.0; the TTM figure through Jun 2017 stood at $561000.0 (up 179.91% YoY), while the FY2025 annual figure was -$280000.0, up 81.7% from the prior year.
- Change in Account Payables improved to $197000.0 in Q2 2017 per MGNX's latest filing, from -$2.2 million in the prior quarter.
- Across five years, Change in Account Payables topped out at $2.4 million in Q4 2016 and bottomed at -$2.7 million in Q4 2014.
- Historically, Change in Account Payables has averaged -$112611.1 across 5 years, with a median of -$96000.0 in 2015.
- On a YoY basis, Change in Account Payables climbed as much as 496.97% in 2017 and fell as far as 472.94% in 2017.
- Macrogenics' Change in Account Payables stood at $1.4 million in 2013, then slumped by 298.32% to -$2.7 million in 2014, then surged by 61.93% to -$1.0 million in 2015, then surged by 328.5% to $2.4 million in 2016, then sank by 91.67% to $197000.0 in 2017.
- Business Quant data shows MGNX's Change in Account Payables at $197000.0 in Q2 2017, -$2.2 million in Q1 2017, and $2.4 million in Q4 2016.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | -66.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -8.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 5.03 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 37.53 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | Macrogenics | 284.90 Mn | 171.00 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2017 | 197,000.00 |
| Mar 31, 2017 | -2.22 Mn |
| Dec 31, 2016 | 2.37 Mn |
| Sep 30, 2016 | 222,000.00 |
| Jun 30, 2016 | 33,000.00 |
| Mar 31, 2016 | -388,000.00 |
| Dec 31, 2015 | -1.04 Mn |
| Sep 30, 2015 | 688,000.00 |
| Jun 30, 2015 | 409,000.00 |
| Mar 31, 2015 | -225,000.00 |
| Dec 31, 2014 | -2.72 Mn |
| Sep 30, 2014 | 411,000.00 |
| Jun 30, 2014 | -1.16 Mn |
| Mar 31, 2014 | 1.96 Mn |
| Dec 31, 2013 | 1.37 Mn |
| Sep 30, 2013 | -321,000.00 |
| Jun 30, 2013 | -675,102.00 |
| Mar 31, 2013 | -944,898.00 |
| Dec 31, 2012 | -1.87 Mn |